ERBB2 and central nervous system neoplasm: Another TKI-PET tracer that has been used in CNS tumors is [11C]C-lapatinib, which was used to study the target expression and accessibility of HER2 in three patients with brain metastases from (HER2-positive) breast cancer [139].